Search

everythinglearnresearchcommunity

for

Search:↓

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

IBD treatment is complex and requires personalized approaches due to varying patient responses.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

High-dose methotrexate can cause severe skin and nail issues.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Radiotherapy was effective for treating a large scalp plaque of Bowen's disease when other treatments failed.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

MicroRNAs could help assess and manage multiple chronic diseases.

Some bacteria use arsenic compounds as antibiotics, and others have evolved resistance; a particular arsenic-based compound shows potential as a new antimalarial treatment.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Medication 1 improved hair quality and growth more effectively than medication 2 and the placebo.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.